Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA

被引：37
|
作者：
Morrison, Vicki A. [1 ]
Bell, Jill A. [2 ]
Hamilton, Laurie [3 ]
Ogbonnaya, Augustina [3 ]
Shih, Huai-Che [3 ]
Hennenfent, Kristin [3 ]
Eaddy, Michael [3 ]
Shou, Yaping [2 ]
Galaznik, Aaron [2 ]
机构：
[1] Univ Minnesota, Hennepin Cty Med Ctr, Hematol Oncol & Infect Dis, 701 Pk Ave Ste 310, Minneapolis, MN 55415 USA
[2] Millennium Pharmaceut Inc, 40 Landsdowne St, Cambridge, MA USA
[3] Xcenda LLC, 4114 Woodlands Pkwy,Suite 500, Palm Harbor, FL 34685 USA
来源：
FUTURE ONCOLOGY | 2018年 / 14卷 / 25期
关键词：
cost; diffuse large B-cell lymphoma; economic burden; follicular lymphoma; healthcare utilization; real-world; retrospective; treatment; NON-HODGKIN-LYMPHOMA; UNITED-STATES; EPIDEMIOLOGY;
D O I：
10.2217/fon-2018-0267
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: Evaluate healthcare costs and utilization of treated diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) patients. Materials & methods: Adults with newly diagnosed DLBCL and FL between 1 January 2008 and 31 October 2015 were identified in the Optum claims database. Healthcare costs and utilization were assessed from diagnosis date until end of follow-up. Results: A total of 1267 DLBCL- and 1595 FL-treated patients were identified. Mean per-patient, per-month cost during follow-up was US$11,890 for DLBCL and US$10,460 for FL. Healthcare costs and utilization decreased from year 1 to 2 following diagnosis, due to a decrease in chemotherapy services, inpatient admissions and other outpatient services. Conclusion: The economic burden of treated DLBCL and FL is considerable, especially in the first year following diagnosis.
引用
收藏
页码：2627 / 2642
页数：16
相关论文
共 50 条
  • [1] Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA
    Ren, Jinma
    Asche, Carl V.
    Shou, Yaping
    Galaznik, Aaron
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (06) : 393 - 402
  • [2] Economic burden in treated Japanese patients with relapsed/refractory large B-cell lymphoma
    Tsutsue, Saaya
    Makita, Shinichi
    Yi, Jingbo
    Crawford, Bruce
    FUTURE ONCOLOGY, 2021, 17 (33) : 4511 - 4525
  • [3] Cost burden of diffuse large B-cell lymphoma
    Harkins, R. Andrew
    Patel, Sharvil P.
    Flowers, Christopher R.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (06) : 645 - 661
  • [4] SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC BURDEN ASSOCIATED WITH DIFFUSE LARGE B CELL LYMPHOMA AND FOLLICULAR LYMPHOMA
    Galaznik, A.
    Bell, J.
    Huelin, R.
    Hoog, M.
    Bhagnani, T. D.
    Guo, Y.
    Stokes, M. E.
    Seal, B.
    Shou, Y.
    VALUE IN HEALTH, 2017, 20 (05) : A233 - A233
  • [5] Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
    Gonzalez-Rincon, Julia
    Mendez, Miriam
    Gomez, Sagrario
    Garcia, Juan F.
    Martin, Paloma
    Bellas, Carmen
    Pedrosa, Lucia
    Rodriguez-Pinilla, Socorro M.
    Camacho, Francisca I.
    Quero, Cristina
    Perez-Callejo, David
    Rueda, Antonio
    Llanos, Marta
    Gomez-Codina, Jose
    Piris, Miguel A.
    Montes-Moreno, Santiago
    Barcena, Carmen
    Rodriguez-Abreu, Delvys
    Menarguez, Javier
    De la Cruz-Merino, Luis
    Monsalvo, Silvia
    Parejo, Consuelo
    Royuela, Ana
    Kwee, Ivo
    Cascione, Luciano
    Arribas, Alberto
    Bertoni, Francesco
    Mollejo, Manuela
    Provencio, Mariano
    Sanchez-Beato, Margarita
    PLOS ONE, 2019, 14 (02):
  • [6] Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
    Klanova, Magdalena
    Oestergaard, Mikkel Z.
    Trneny, Marek
    Hiddemann, Wolfgang
    Marcus, Robert
    Sehn, Laurie H.
    Vitolo, Umberto
    Bazeos, Alexandra
    Goede, Valentin
    Zeuner, Harald
    Knapp, Andrea
    Sahin, Deniz
    Spielewoy, Nathalie
    Bolen, Christopher R.
    Cardona, Andres
    Klein, Christian
    Venstrom, Jeffrey M.
    Nielsen, Tina
    Fingerle-Rowson, Guenter
    CLINICAL CANCER RESEARCH, 2019, 25 (15) : 4634 - 4643
  • [7] Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma
    Tada, Kohei
    Kim, Sung-Won
    Asakura, Yoshitaka
    Hiramoto, Nobuhiro
    Yakushijin, Kimikazu
    Kurosawa, Saiko
    Tajima, Kinuko
    Mori, Shin-ichiro
    Heike, Yuji
    Tanosaki, Ryuji
    Maeshima, Akiko Miyagi
    Taniguchi, Hirokazu
    Furuta, Koh
    Kagami, Yoshikazu
    Matsuno, Yoshihiro
    Tobinai, Kensei
    Takaue, Yoichi
    Fukuda, Takahiro
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (08) : 770 - 775
  • [8] Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma
    Maziarz, Richard T.
    Hao, Yanni
    Guerin, Annie
    Gauthier, Genevieve
    Gauthier-Loiselle, Marjolaine
    Thomas, Simu K.
    Eldjerou, Lamis
    LEUKEMIA & LYMPHOMA, 2018, 59 (05) : 1133 - 1142
  • [9] A Fully Automated Measurement of Total Metabolic Tumor Burden in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
    Jemaa, Skander
    Fredrickson, Jill
    Coimbra, Alexandre
    Carano, Richard A. D.
    El-Galaly, Tarec Christoffer C.
    Knapp, Andrea
    Nielsen, Tina G.
    Sahin, Deniz
    Bengtsson, Thomas
    de Crespigny, Alex
    BLOOD, 2019, 134
  • [10] Genetic Instability (MSI, EMAST) in Patients with Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
    Sychevskaya, Kseniia
    Risinskaya, Natalya
    Kravchenko, Sergey
    Nikulina, Elena
    Yushkova, Anna
    Magomedova, Aminat
    Babaaeva, Fatima
    Sudarikov, Andrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S283 - S283
12345